Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonetta Salemi

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Drugs - Real World Outcomes|April 30, 2020
Using INTERCheck<sup>®</sup> to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to PolypharmacyAntonio Martocchia, Valerio Spuntarelli, Francesco Aiello, et al.
Journal of Translational Medicine|February 23, 2017
TCD4<sup>pos</sup> lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agentsAndrea Picchianti Diamanti, Bruno Laganà, Maria Christina Cox, et al.
Microorganisms|December 17, 2020
Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis PatientsAndrea Picchianti Diamanti, Concetta Panebianco, Gerardo Salerno, et al.
Microorganisms|November 21, 2020
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in ItalyAndrea Picchianti Diamanti, Maria Sofia Cattaruzza, Roberta Di Rosa, et al.
Vaccines|December 24, 2025
Coverage and Drivers of Vaccinations in Patients with Autoimmune Rheumatic Diseases: An Italian Multicentric StudyIlaria Anna Bellofatto, Valentino Paci, Fabrizio Conti, et al.
Microorganisms|July 2, 2021
May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of LiteratureMichela Ileen Biondo, Chiara Fiorentino, Severino Persechino, et al.
Arthritis Research & Therapy|November 4, 2025
Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS studyAndrea Picchianti Diamanti, Valentino Paci, Michele Maria Luchetti Gentiloni, et al.
Microorganisms|November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMarco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Expert Opinion on Biological Therapy|May 14, 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter studyMaria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.
Biomedicines|March 29, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid ArthritisAndrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Drugs - Real World Outcomes|April 30, 2020
Using INTERCheck<sup>®</sup> to Evaluate the Incidence of Adverse Events and Drug-Drug Interactions in Out- and Inpatients Exposed to PolypharmacyAntonio Martocchia, Valerio Spuntarelli, Francesco Aiello, et al.
Journal of Translational Medicine|February 23, 2017
TCD4<sup>pos</sup> lymphocytosis in rheumatoid and psoriatic arthritis patients following TNFα blocking agentsAndrea Picchianti Diamanti, Bruno Laganà, Maria Christina Cox, et al.
Microorganisms|December 17, 2020
Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis PatientsAndrea Picchianti Diamanti, Concetta Panebianco, Gerardo Salerno, et al.
Microorganisms|November 21, 2020
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in ItalyAndrea Picchianti Diamanti, Maria Sofia Cattaruzza, Roberta Di Rosa, et al.
Vaccines|December 24, 2025
Coverage and Drivers of Vaccinations in Patients with Autoimmune Rheumatic Diseases: An Italian Multicentric StudyIlaria Anna Bellofatto, Valentino Paci, Fabrizio Conti, et al.
Microorganisms|July 2, 2021
May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of LiteratureMichela Ileen Biondo, Chiara Fiorentino, Severino Persechino, et al.
Arthritis Research & Therapy|November 4, 2025
Clinical and ultrasound remission at 48 weeks of upadacitinib in rheumatoid arthritis: real-world results from the Italian multicenter UPARAREMUS studyAndrea Picchianti Diamanti, Valentino Paci, Michele Maria Luchetti Gentiloni, et al.
Microorganisms|November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in ItalyMarco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Expert Opinion on Biological Therapy|May 14, 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter studyMaria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.
Biomedicines|March 29, 2023
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid ArthritisAndrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Pageof 4